See more : Computime Group Limited (0320.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Canzon Israel Ltd (CNZN.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Canzon Israel Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Aptevo Therapeutics Inc. (APVO) Income Statement Analysis – Financial Results
- Ceylon Graphite Corp. (CYL.V) Income Statement Analysis – Financial Results
- Utility Business Alliance Public Company Limited (UBA.BK) Income Statement Analysis – Financial Results
- Brookfield Asset Management Ltd. (BAM) Income Statement Analysis – Financial Results
- Permex Petroleum Corporation (OIL.CN) Income Statement Analysis – Financial Results
Canzon Israel Ltd (CNZN.TA)
About Canzon Israel Ltd
Canzon Israel Ltd, a holding company, provides funding for construction of residential and commercial projects in Israel. It also offers real estate, and logistics services. The company was formerly known as User Trend Ltd and changed its name into Canzon Israel Ltd in June 2019. Canzon Israel Ltd was incorporated in 1999 and is based in Tel Aviv-Yafo, Israel.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 99.00K | 1.19M | 59.00K | 277.00K | 24.00K | 0.00 | 4.07M | 13.29M | 12.03M | 9.72M | 12.24M | 8.13M |
Cost of Revenue | 0.00 | 596.00K | 67.00K | 600.00K | 104.00K | 0.00 | 3.23M | 8.92M | 8.37M | 8.05M | 8.81M | 4.91M |
Gross Profit | 99.00K | 596.00K | -8.00K | -323.00K | -80.00K | 0.00 | 844.00K | 4.37M | 3.65M | 1.67M | 3.43M | 3.21M |
Gross Profit Ratio | 100.00% | 50.00% | -13.56% | -116.61% | -333.33% | 0.00% | 20.73% | 32.90% | 30.38% | 17.19% | 28.04% | 39.53% |
Research & Development | 0.00 | 0.00 | 22.00K | 1.09M | 829.00K | 66.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 2.92M | 3.40M | 3.44M | 7.17M | 7.05M | 286.00K | 2.01M | 3.12M | 3.38M | 3.47M | 3.18M | 2.90M |
Selling & Marketing | 0.00 | 0.00 | 135.00K | 3.69M | 3.00M | 89.00K | 589.00K | 1.41M | 1.22M | 627.00K | 1.48M | 1.06M |
SG&A | 2.92M | 3.40M | 3.57M | 10.86M | 10.06M | 375.00K | 2.60M | 4.54M | 4.61M | 4.09M | 4.66M | 3.95M |
Other Expenses | 1.94M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 4.86M | 4.37M | 3.08M | 11.70M | 55.67M | 441.00K | 217.00K | 4.54M | 4.76M | 3.92M | 4.60M | 3.38M |
Cost & Expenses | 4.86M | 4.96M | 3.14M | 12.30M | 55.77M | 441.00K | 3.44M | 13.45M | 13.13M | 11.97M | 13.41M | 8.30M |
Interest Income | 118.00K | 25.00K | 23.00K | 15.00K | 238.00K | 0.00 | 31.00K | 13.00K | 80.00K | 105.00K | 111.00K | 16.00K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.00K | 14.00K | 83.00K | 58.00K | 53.00K | 56.00K | 56.00K | 192.00K | 169.00K | 145.00K | 185.00K | 357.00K |
EBITDA | -3.87M | -2.79M | -3.52M | -12.22M | -10.91M | -385.00K | -1.70M | 29.00K | -785.00K | -2.28M | -1.04M | -381.00K |
EBITDA Ratio | -3,911.11% | -234.23% | -5,966.10% | -4,410.11% | -45,466.67% | 0.00% | -41.66% | 0.22% | -6.53% | -23.43% | -8.48% | -4.69% |
Operating Income | -4.76M | -2.81M | -3.60M | -12.27M | -10.97M | -441.00K | -1.75M | -163.00K | -954.00K | -2.42M | -1.22M | -738.00K |
Operating Income Ratio | -4,810.10% | -235.40% | -6,106.78% | -4,431.05% | -45,687.50% | 0.00% | -43.04% | -1.23% | -7.93% | -24.93% | -9.99% | -9.08% |
Total Other Income/Expenses | 19.00K | -990.00K | 495.00K | 238.00K | -452.00K | 0.00 | 31.00K | 13.00K | -48.00K | 66.00K | -51.00K | 553.00K |
Income Before Tax | -4.74M | -3.80M | -3.11M | -12.04M | -55.99M | -441.00K | 658.00K | -150.00K | -1.18M | -2.36M | -1.27M | -185.00K |
Income Before Tax Ratio | -4,790.91% | -318.46% | -5,267.80% | -4,345.13% | -233,275.00% | 0.00% | 16.16% | -1.13% | -9.84% | -24.25% | -10.41% | -2.28% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 282.00K | 0.00 | -105.14K | 475.00K | 475.00K | 108.00K | 256.00K | 529.00K | 310.00K |
Net Income | -4.74M | -3.80M | -3.11M | -12.32M | -55.99M | -441.00K | 122.00K | 280.00K | -1.29M | -2.44M | -807.00K | -514.00K |
Net Income Ratio | -4,790.91% | -318.46% | -5,267.80% | -4,446.93% | -233,275.00% | 0.00% | 3.00% | 2.11% | -10.74% | -25.14% | -6.59% | -6.32% |
EPS | -1.15 | -0.92 | -0.76 | -3.16 | -25.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | -1.15 | -0.92 | -0.76 | -3.16 | -25.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 4.11M | 4.11M | 4.11M | 3.89M | 2.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 4.11M | 4.11M | 4.11M | 3.89M | 2.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports